Balyasny Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.59M | Buy |
1,507,782
+1,297,841
| +618% | +$2.23M | ﹤0.01% | 1083 |
|
2025
Q1 | $699K | Sell |
209,941
-2,609,858
| -93% | -$8.69M | ﹤0.01% | 1471 |
|
2024
Q4 | $20.9M | Sell |
2,819,799
-1,652,777
| -37% | -$12.2M | 0.03% | 488 |
|
2024
Q3 | $42M | Sell |
4,472,576
-67,984
| -1% | -$638K | 0.07% | 266 |
|
2024
Q2 | $36.4M | Buy |
4,540,560
+3,339,696
| +278% | +$26.8M | 0.06% | 300 |
|
2024
Q1 | $17.8M | Sell |
1,200,864
-2,725,295
| -69% | -$40.4M | 0.03% | 501 |
|
2023
Q4 | $31.9M | Sell |
3,926,159
-550,677
| -12% | -$4.48M | 0.06% | 314 |
|
2023
Q3 | $20.4M | Buy |
4,476,836
+2,937,029
| +191% | +$13.4M | 0.04% | 428 |
|
2023
Q2 | $10.8M | Sell |
1,539,807
-1,195,779
| -44% | -$8.42M | 0.02% | 571 |
|
2023
Q1 | $16.7M | Buy |
2,735,586
+2,731,832
| +72,771% | +$16.7M | 0.04% | 467 |
|
2022
Q4 | $24K | Sell |
3,754
-1,739,778
| -100% | -$11.1M | ﹤0.01% | 2019 |
|
2022
Q3 | $16.7M | Buy |
1,743,532
+233,743
| +15% | +$2.24M | 0.05% | 402 |
|
2022
Q2 | $16.7M | Buy |
1,509,789
+415,765
| +38% | +$4.59M | 0.05% | 395 |
|
2022
Q1 | $18.2M | Buy |
1,094,024
+297,189
| +37% | +$4.95M | 0.06% | 352 |
|
2021
Q4 | $15.2M | Sell |
796,835
-166,625
| -17% | -$3.18M | 0.05% | 426 |
|
2021
Q3 | $23.8M | Buy |
963,460
+354,336
| +58% | +$8.74M | 0.1% | 254 |
|
2021
Q2 | $15.8M | Buy |
609,124
+441,812
| +264% | +$11.5M | 0.08% | 327 |
|
2021
Q1 | $5.3M | Buy |
+167,312
| New | +$5.3M | 0.03% | 561 |
|
2020
Q4 | – | Sell |
-437,864
| Closed | -$14.4M | – | 1324 |
|
2020
Q3 | $14.4M | Buy |
+437,864
| New | +$14.4M | 0.11% | 240 |
|
2020
Q2 | – | Sell |
-355,779
| Closed | -$10.7M | – | 1137 |
|
2020
Q1 | $10.7M | Buy |
+355,779
| New | +$10.7M | 0.13% | 201 |
|
2019
Q2 | – | Sell |
-38,011
| Closed | -$361K | – | 1435 |
|
2019
Q1 | $361K | Sell |
38,011
-13,104
| -26% | -$124K | ﹤0.01% | 1161 |
|
2018
Q4 | $452K | Sell |
51,115
-93,172
| -65% | -$824K | ﹤0.01% | 1022 |
|
2018
Q3 | $1.62M | Buy |
144,287
+109,210
| +311% | +$1.23M | 0.01% | 846 |
|
2018
Q2 | $449K | Buy |
+35,077
| New | +$449K | ﹤0.01% | 1201 |
|